Randomized controlled trial of sugammadex or neostigmine on postoperative pulmonary complications in elderly patients undergoing urologic surgery

Randomized controlled trial of sugammadex or neostigmine for reversal of neuromuscular block on the incidence of postoperative pulmonary complications in elderly patients undergoing urologic surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0005630

Enrollment

180

Registered

2020-11-24

Start date

2020-11-18

Completion date

Unknown

Last updated

2020-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : At the end of the surgery, when the Train-of-four counts is 2 or more, the anesthesiologist will administer sugammadex (experimental group) 2mg/kg or neostigmine (control group) 0.07mg/kg (maxi

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Patients undergoing general anesthesia for transurethral resection of prostate or bladder tumor - American Society of Anesthesiologists (ASA) physical status I-III

Exclusion criteria

Exclusion criteria: - Severe chronic renal disease - Severe chronic liver disease - Allergy to sugammadex or neostigmine - Pregnancy - Patients who lack decision-making ability

Design outcomes

Primary

Measure	Time frame
Total incidence of postoperative pulmonary complications	—

Secondary

Measure	Time frame
The incidence of residual neuromuscular block;Time taken to extubation after administation of reverse agents;Time taken to exit the operating room after administation of reverse agents;Time spent in the postanesthesia care unit;The incidence of postoperative complications;The length of hospital stay;Readmission within 30 days after surgery	—

Countries

Korea, Republic of

Contacts

Public ContactMin Hur

Ajou University Hospital

Outcome results